Filing Details
- Accession Number:
- 0001209191-21-051172
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-12 17:07:30
- Reporting Period:
- 2021-08-11
- Accepted Time:
- 2021-08-12 17:07:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1829802 | Sensei Biotherapeutics Inc. | SNSE | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1594129 | Hamilton Robert Pierce | C/O Sensei Biotherapeutics, Inc. 1405 Research Blvd, Suite 125 Rockville MD 20850 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-08-11 | 16,030 | $7.34 | 0 | No | 4 | S | Indirect | By spouse |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By spouse |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.10 to $7.81, inclusive. The reporting person undertakes to provide to Sensei Biotherapeutics, Inc., any security holder of Sensei Biotherapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
Billionaire Hedge Funds
